Thyroid Hormone Changes in the Northern Area of Tianjin during the COVID-19 Pandemic
Table 1
Changes in thyroid function during the pandemic.
Assessment characteristics
Before matching
After matching
Group A (N = 932)
Group B (N = 224)
Group B vs A
Group A (N = 224)
Group B (N = 224)
Group B vs A
t or χ2 value
t or χ2 value
Gender
Male
258 (27.68%)
85 (37.95%)
9.117A
<0.01
85 (37.95%)
85 (37.95%)
0A
1
Female
674 (72.32%)
139 (62.05%)
139 (62.05%)
139 (62.05%)
Age (year)
57.51 ± 15.89
58.97 ± 16.91
1.222B
0.222
58.61 ± 16.18
58.97 ± 6.91
0.234B
0.815
Basic disease1
Yes
432 (46.35%)
107 (47.76%)
0.145A
0.703
98 (43.75%)
107 (47.76%)
0.728A
0.393
No
500 (53.65%)
117 (52.24%)
126 (56.25%)
117 (52.24%)
History of thyroid
Yes
417 (44.74%)
82 (36.61%)
4.872A
<0.05
82 (36.61%)
82 (36.61%)
0A
1
No
515 (55.26%)
142 (63.39%)
142 (63.39%)
142 (63.39%)
Diagnosis of thyroid function
Normal
404 (43.35%)
68 (30.36%)
12.615A
<0.01
15 (6.70%)
68 (30.36%)
41.539A
<0.01
Abnormal
528 (56.65%)
156 (69.64%)
209 (93.30%)
156 (69.64%)
Note: 1basic diseases include coronary heart disease, cerebral infarction, cerebral ischemia, respiratory disease, hematologic disease, tumor, and other medical history, Group A: control group; Group B: COVID-19 outbreak group; A: chi-square test; B: t-test.